Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 826 AL 840

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial

Hauser RA, Hsu A, Kell S, Espay AJ, Sethi K, Stacy M, Ondo W, O'Connell M, Gupta S; IPX066 ADVANCE-PD investigators.

Lancet Neurol. 2013 Apr;12(4):346-56. doi: 10.1016/S1474-4422(13)70025-5. Epub 2013 Feb 26.

Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease

Shine JM, Matar E, Ward PB, Bolitho SJ, Gilat M, Pearson M, Naismith SL, Lewis SJ.

Brain. 2013 Apr;136(Pt 4):1204-15. doi: 10.1093/brain/awt049. Epub 2013 Mar 12.

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes

Bajaj N, Hauser RA, Grachev ID.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1288-95. doi: 10.1136/jnnp-2012-304436. Epub 2013 Mar 13.

When the going gets tough: how to select patients with Parkinson's disease for advanced therapies

Worth PF.

Pract Neurol. 2013 Jun;13(3):140-52. doi: 10.1136/practneurol-2012-000463. Epub 2013 Mar 13.

[Milk phospholipids as nutraceutic]

Ambroziak A, Cichosz G.

Pol Merkur Lekarski. 2013 Jan;34(199):62-6.

Robot-assisted gait training versus equal intensity treadmill training in patients with mild to moderate Parkinson's disease: a randomized controlled trial

Picelli A, Melotti C, Origano F, Neri R, Waldner A, Smania N.

Parkinsonism Relat Disord. 2013 Jun;19(6):605-10. doi: 10.1016/j.parkreldis.2013.02.010. Epub 2013 Mar 13.

Pathological gambling in Parkinson's disease. A comprehensive review

Santangelo G, Barone P, Trojano L, Vitale C.

Parkinsonism Relat Disord. 2013 Jul;19(7):645-53. doi: 10.1016/j.parkreldis.2013.02.007. Epub 2013 Mar 11.

Red/near-infrared irradiation therapy for treatment of central nervous system injuries and disorders

Fitzgerald M, Hodgetts S, Van Den Heuvel C, Natoli R, Hart NS, Valter K, Harvey AR, Vink R, Provis J, Dunlop SA.

Rev Neurosci. 2013;24(2):205-26. doi: 10.1515/revneuro-2012-0086.

Physical exercise and Parkinson's disease: influence on symptoms, disease course and prevention

Grazina R, Massano J.

Rev Neurosci. 2013;24(2):139-52. doi: 10.1515/revneuro-2012-0087.

Psychosis from subthalamic nucleus deep brain stimulator lesion effect

Widge AS, Agarwal P, Giroux M, Farris S, Kimmel RJ, Hebb AO.

Surg Neurol Int. 2013;4:7. doi: 10.4103/2152-7806.106265. Epub 2013 Jan 18.

Different diagnostic criteria for Parkinson disease: what are the pitfalls?

Bhidayasiri R, Reichmann H.

J Neural Transm (Vienna). 2013 Apr;120(4):619-25. doi: 10.1007/s00702-013-1007-z. Epub 2013 Mar 15.

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome

Duval F, Flabeau O, Razafimahefa J, Spampinato U, Tison F.

Mov Disord. 2013 Sep;28(10):1464. doi: 10.1002/mds.25416. Epub 2013 Mar 13.

VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations

Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP, Winborn BJ, Moore J, Lee JY, Yao TP, Pallanck L, Kundu M, Taylor JP.

Neuron. 2013 Apr 10;78(1):65-80. doi: 10.1016/j.neuron.2013.02.029. Epub 2013 Mar 14.

New perspectives on the pathophysiology of Parkinson's disease as assessed by saccade performance: a clinical review

Terao Y, Fukuda H, Ugawa Y, Hikosaka O.

Clin Neurophysiol. 2013 Aug;124(8):1491-506. doi: 10.1016/j.clinph.2013.01.021. Epub 2013 Mar 13.

Exploring the accessible conformations of N-terminal acetylated α-synuclein

Moriarty GM, Janowska MK, Kang L, Baum J.

FEBS Lett. 2013 Apr 17;587(8):1128-38. doi: 10.1016/j.febslet.2013.02.049. Epub 2013 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias